Cohort | Percentage NRI (95% CI) | HR (95% CI) |
---|
NEAT vs IMDC | NEAT vs MSKCC+
| NEAT | IMDC | MSKCC |
---|
Validation | 7.1a (–24.8, 39.0) | 25.4b (–25.7, 76.5) | 37.89 (4.1, 353.8) | 7.317a (1.54, 34.69) | 14.39b (1.24, 165.7) |
Development | 25.0 (–34.8, 84.8) | 23.3 (–28.3, 74.9) | 10.649 (1.35, 84.08) | 1.378 (0.44, 4.36) | 3.577 (1.00, 12.85) |
-
NRI net reclassification improvement, HR Hazard ratio, NEAT N-cadherin EPCAM Age mTOR multivariate model, IMDC International Metastatic Database Consortium, MSKCC Memorial Sloan Kettering Cancer Center
- Values reflect assignment of either high risk or low risk status (methods)
-
a
n = 20 due to data availability
-
b
n = 16 due to data availability